Cart
sales@molnova.com
BP14979
CAS No. 1000036-77-0
BP14979( —— )
Catalog No. M34192 CAS No. 1000036-77-0
BP14979 is a dopamine D3 receptor agonist that can be used to study neurological disorders.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 686 | In Stock |
|
| 10MG | 938 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBP14979
-
NoteResearch use only, not for human use.
-
Brief DescriptionBP14979 is a dopamine D3 receptor agonist that can be used to study neurological disorders.
-
DescriptionBP14979 is a dopamine D3 receptor agonist that can be used to study neurological disorders.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetDopamine Receptor
-
RecptorDopamine Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1000036-77-0
-
Formula Weight398.54
-
Molecular FormulaC23H34N4O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(#N)C=1C=C(N2CCN(CC[C@@H]3CC[C@@H](NC(CCOC)=O)CC3)CC2)C=CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Dehydroevodiamine
Dehydroevodiamine, a constituent of Evodia rutaecarpa, has various biological effects such as hypotensive, negative chronotropic, ion channel depressant, inhibition of nitric oxide production and cerebral blood flow enhancing activities.
-
SB-277011 hydrochlor...
SB-277011 hydrochloride (SB-277011A hydrochloride) is a potent, selective, and orally active dopamine D3 receptor (D3R) antagonist that crosses the blood-brain barrier, with Ki values of 10.7 nM for rodent D3R and 11.2 nM for human D3R.
-
DOPEXAMINE
Dopexamine is a dopaminergic agonistDopexamine hydrochloride has interesting vasodilator properties, with marked intrinsic agonist activity at beta-2 adrenoreceptors and a lesser agonist activity at dopaminergic receptors (DA1 and DA2).?
